Litigation Details for RIGEL PHARMACEUTICALS, INC. v. ANNORA PHARMA PRIVATE LTD. (D.N.J. 2022)
✉ Email this page to a colleague
RIGEL PHARMACEUTICALS, INC. v. ANNORA PHARMA PRIVATE LTD. (D.N.J. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-07-25 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
Jury Demand | None | Referred To | Cathy L. Waldor |
Parties | HETERO LABS LTD. | ||
Patents | 8,263,122; 8,652,492 | ||
Attorneys | ERIC I. ABRAHAM | ||
Firms | Eric I. Abraham | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in RIGEL PHARMACEUTICALS, INC. v. ANNORA PHARMA PRIVATE LTD.
Details for RIGEL PHARMACEUTICALS, INC. v. ANNORA PHARMA PRIVATE LTD. (D.N.J. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2024-02-07 | 59 | Opinion AND Order | United States Patent Nos. 8,263,122 (“the ’122 patent”) and 8,652,492 (“the ’492 patent”). Plaintiff …intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history… These cases arise from patent infringement litigation involving two patents generally directed to compositions…Plaintiff Rigel owns these patents and has sued the Defendants for patent infringement. The parties seek claim… It is a bedrock principle of patent law that the claims of a patent define the invention to | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |